SNT Biotech delivers fully integrated at-home screening solutions for health plans, closing gaps across cervical, colorectal, diabetes, and kidney care in underserved communities, from member outreach to results in our own accredited lab.
Convenient, at-home testing that reaches members wherever they are, with no clinic visit required.
Catching disease earlier means simpler treatment, better outcomes, and lower downstream cost.
Comprehensive screening closes the measures that move your quality and Star performance.
Accessible screening bridges care gaps for underserved and hard-to-reach populations.
Easy, personalized, omni-channel outreach increases participation and completion.
Partner with a certified minority and women-owned business to advance supplier diversity.
SNT Biotech runs every step end to end, from your member list to results in our own lab, with real-time population health dashboards, so your data stays clean and your reporting stays audit-ready.
Your team gets a live console: outreach, kit tracking, results, and numerator closure by measure, updating in real time as members complete their screening, with HEDIS supplemental data files on demand.
See the platform →Illustrative dashboard. Metrics shown are representative of program reporting, not a specific client.
At-home HPV self-collection using the FDA-approved BD Onclarity assay, delivered through our partnership with Waters Corporation. NCQA confirms HPV testing closes the CCS gap whether the sample is collected at home or in a clinic.
Explore the cervical program →
At-home fecal immunochemical testing, a simple path to screening completion.
At-home HbA1c, a triple-weighted measure in Medicare Advantage Star Ratings.
At-home eGFR and uACR for the Kidney Health Evaluation for patients with diabetes.
Biometric screening, chlamydia (CHL), and additional measures on one platform.
Samples are processed in the CLIA-certified, COLA-accredited lab we own and operate, overseen by board-certified molecular biologists and pathologists. That is how we keep quality high, turnaround fast, and reporting audit-ready.
Independently audited controls that protect member data end to end.
Average at-home kit return rate for a Medicaid health plan, well above program norms, with documented, audit-ready numerator closure your quality team can stand behind.
An at-home colorectal (FIT) screening program SNT Biotech ran for a regional health plan.
FIT kits mailed
Completed screenings
Return rate
Members had polyps removed
Branded, multilingual text, phone, email, and mail move members from kit shipped to sample returned, with opt-in and opt-out on every message.
These are the most comprehensive dashboards we have seen from any vendor in this space.
A certified minority and women-owned business, built by a founder with a track record of growth.
Yes. Our at-home HPV self-collection kit uses the FDA-approved BD Onclarity HPV assay, and NCQA has confirmed that HPV testing closes the Cervical Cancer Screening gap whether the sample is collected at home or in a clinic.
Your quality team gets a real-time console: outreach status, kit tracking, results, and numerator closure by measure, updating as members complete their screening, plus on-demand HEDIS supplemental data file exports.
We own the entire workflow, from your member list through our own CLIA and COLA accredited lab, results delivery, and audit-ready reporting. Health plans work with one accountable partner instead of stitching together four or five vendors.
We close gaps across your quality program, cervical (CCS), colorectal (COL), diabetes (GSD), kidney (KED), chlamydia (CHL) and more, for Medicaid, Medicare Advantage, and commercial plans, as well as employers.
See how SNT Biotech closes care gaps and strengthens quality performance for your plan, on one fully integrated platform.